Proteasome inhibition

mechanism of action.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The ubiquitin-proteasome pathway plays a significant role in neoplastic growth and metastasis. The proteasome is responsible for most intracellular protein degradation and regulates numerous cellular functions. Aberrations in cell cycle control caused by altered levels of specific cell-cycle related proteins may lead to oncogenesis. Dysregulation of NF-kappaB signaling also is common to many malignancies and is one of the critical pathways affected by proteasome inhibition. The proteasome structure, in the context of the ubiquitin-proteasome pathway, is discussed. Proteasome inhibitors, such as bortezomib, have the potential to target specific protein substrates, leading to decreased tumor cell growth and increased apoptosis.

Original languageEnglish (US)
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume2 Suppl 4
StatePublished - Nov 2004

Fingerprint

Proteasome Endopeptidase Complex
Ubiquitin
Cell Cycle Proteins
Proteasome Inhibitors
Critical Pathways
NF-kappa B
Growth
Cell Cycle Checkpoints
Proteolysis
Neoplasms
Carcinogenesis
Apoptosis
Neoplasm Metastasis
Proteins

ASJC Scopus subject areas

  • Oncology

Cite this

Proteasome inhibition : mechanism of action. / DeMartino, George N.

In: Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 2 Suppl 4, 11.2004.

Research output: Contribution to journalArticle

@article{ba4a64a1ca3543f7b1f36eab43561377,
title = "Proteasome inhibition: mechanism of action.",
abstract = "The ubiquitin-proteasome pathway plays a significant role in neoplastic growth and metastasis. The proteasome is responsible for most intracellular protein degradation and regulates numerous cellular functions. Aberrations in cell cycle control caused by altered levels of specific cell-cycle related proteins may lead to oncogenesis. Dysregulation of NF-kappaB signaling also is common to many malignancies and is one of the critical pathways affected by proteasome inhibition. The proteasome structure, in the context of the ubiquitin-proteasome pathway, is discussed. Proteasome inhibitors, such as bortezomib, have the potential to target specific protein substrates, leading to decreased tumor cell growth and increased apoptosis.",
author = "DeMartino, {George N.}",
year = "2004",
month = "11",
language = "English (US)",
volume = "2 Suppl 4",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",

}

TY - JOUR

T1 - Proteasome inhibition

T2 - mechanism of action.

AU - DeMartino, George N.

PY - 2004/11

Y1 - 2004/11

N2 - The ubiquitin-proteasome pathway plays a significant role in neoplastic growth and metastasis. The proteasome is responsible for most intracellular protein degradation and regulates numerous cellular functions. Aberrations in cell cycle control caused by altered levels of specific cell-cycle related proteins may lead to oncogenesis. Dysregulation of NF-kappaB signaling also is common to many malignancies and is one of the critical pathways affected by proteasome inhibition. The proteasome structure, in the context of the ubiquitin-proteasome pathway, is discussed. Proteasome inhibitors, such as bortezomib, have the potential to target specific protein substrates, leading to decreased tumor cell growth and increased apoptosis.

AB - The ubiquitin-proteasome pathway plays a significant role in neoplastic growth and metastasis. The proteasome is responsible for most intracellular protein degradation and regulates numerous cellular functions. Aberrations in cell cycle control caused by altered levels of specific cell-cycle related proteins may lead to oncogenesis. Dysregulation of NF-kappaB signaling also is common to many malignancies and is one of the critical pathways affected by proteasome inhibition. The proteasome structure, in the context of the ubiquitin-proteasome pathway, is discussed. Proteasome inhibitors, such as bortezomib, have the potential to target specific protein substrates, leading to decreased tumor cell growth and increased apoptosis.

UR - http://www.scopus.com/inward/record.url?scp=70349908019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349908019&partnerID=8YFLogxK

M3 - Article

VL - 2 Suppl 4

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

ER -